| 321/636 | US=108 / Câncer Greenberger JS, Epperly MW. Radioprotective gene therapy: current status and future goals. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 341-75. ISBN 978-0-470-01922-1. TERAPIA GENICA RADIOPROTETORA; CAVIDADE ORAL; OROFARINGE; MNSOD-PL; LIPOSSOMAS DE MANGANES SUPEROXIDO DISMUTASE PLASMIDEO; IRRADIACAO PULMONAR |
| 322/636 | US=108 / Câncer Milsom M, Schambach A, Williams D, Baum C. Chemoprotective gene delivery. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 377-91. ISBN 978-0-470-01922-1. |
| 323/636 | US=110 / Câncer Featon ER, Bommer GT. Progressing from gene mutations to cancer. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 207-22. ISBN 978-0-443-06695-5. MUTACOES NO GENE. CANCER; SELECAO CLONAL; EVOLUCAO DO CANCER; ONCOGENE; GENE SUPRESSOR DE TUMOR DEFEITOS. CANCER |
| 324/636 | US=110 / Câncer Talmadge JE, Cowan KH. Gene therapy in oncology. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 513-30. ISBN 978-0-443-06695-5. NEOPLASIAS; CANCER; TERAPIA GENICA; VETORES; TERAPIA GENETICA DIRIGIDA; ENSAIOS CLINICOS |
| 325/636 | US=9 / Pediatria Gottschalk S, Rooney CM, Brenner MK. Cell and gene therapies. In: Pizzo PA, Poplack DG. Principles and practice of pediatric oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins, 2006. p. 433-51. ISBN 978-0-7817-5492-7. ONCOLOGIA PEDIATRICA; CANCER INFANTIL; CRIANCA; TERAPIAS COM CELULAS; TERAPIA COM GENES; VETORES DE TRANSFERENCIA DE GENES; TERAPIA GENICA |
| 326/636 | US=13 / Biol/Mol Pecorino L. DNA structure and stability: mutations versus repair. In: ___. Molecular biology of cancer: mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008. p. 21-46. ISBN 978-0-19-921148-7. ESTRUTURA DO DNA; MUTACAO; REPARACAO; ESTRUTURA DO GENE; AGENTES CARCINOGENICOS; RADIACAO; CARCINOGENOS QUIMICOS; AGENTES INFECCIOSOS; QUIMIOTERAPIA; RADIOTERAPIA |
| 327/636 | US=13 / Biol/Mol Pecorino L. Regulation of gene expression. In: ___. Molecular biology of cancer: mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008. p. 47-68. ISBN 978-0-19-921148-7. REGULACAO DA EXPRESSAO GENICA; FATORES DE TRANSCRICAO; REGULACAO TRANSCRICIONAL; ESTRUTURA DA CROMATINA; REGULACAO EPIGENETICA DA TRANSCRICAO; MODIFICACAO DA HISTONA; METILACAO DE DNA; EPIGENETICA; CARCINOGENESE; TELOMERES; TELOMERASE |
| 328/636 | US=13 / Biol/Mol Pecorino L. Growth factor signaling and oncogenes. In: ___. Molecular biology of cancer: mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008. p. 69-94. ISBN 978-0-19-921148-7. FATORES DE CRESCIMENTO; SINALIZACAO; ONCOGENES; FATOR DE CRESCIMENTO EPIDERMICO; AUTOFOSFORILACAO; TRANSLOCACAO DE PROTEINAS ESPECIFICAS; ATIVACAO DO GENE RAS; ATIVACAO DO GENE RAF; CASCATA DE MAP QUINASE; REGULACAO DOS FATORES DE TRANSCRICAO; SINALIZACAO CELULAR; COMPORTAMENTO CELULAR; RETROVIRUS; TRANSDUTORES DE SINAL INTRACELULAR; FATORES DE TRANSCRICAO; MECANISMOS DE ATIVACAO ONCOGENICA; INIBIDORES DA QUINASE; DROGAS ANTI-EGFR; DROGAS ANTI-RECEPTORES DO FATOR DE CRESCIMENTO EPIDERMICO |
| 329/636 | US=13 / Biol/Mol Pecorino L. Growth inhibition and tumor suppressor genes. In: ___. Molecular biology of cancer: mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008. p. 113-36. ISBN 978-0-19-921148-7. CANCER; INIBICAO DO CRESCIMENTO DE TUMORES; GENES SUPRESSORES DE TUMORES; GENE DA RETINOBLASTOMA; MUTACAO DO RETINOBLASTOMA; GENE P53; MUTACAO NA VIA P53; SINDROME DE LI-FRAUMENI; INTERACAO DE PROTEINAS COM O DNA VIRAL; PAPILOMAVIRUS HUMANO (HPV); VIA P53 |
| 330/636 | US=13 / Biol/Mol Pecorino L. Apoptosis. In: ___. Molecular biology of cancer: mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008. p. 137-59. ISBN 978-0-19-921148-7. APOPTOSE; MECANISMOS MOLECULARES; VIA EXTRINSECA; VIA INTRISECA; RECEPTORES DE MORTE DA MEMBRANA; MITOCONDRIAS; GENE P53; CANCER; RECEPTORES TRAIL; QUIMIOTERAPIA; DROGAS ANTI-NEOPLASICAS APOPTOTICAS; BCL-2 |
| 331/636 | US=13 / Biol/Mol Pecorino L. Nutrients, hormones, and gene interactions. In: ___. Molecular biology of cancer: mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008. p. 231-57. ISBN 978-0-19-921148-7. NUTRIENTES; HORMONIOS; INTERACAO GENICA; CONTAMINANTES CANCERIGENOS; DEFICIENCIAS ALIMENTARES; OBESIDADE; PREVENCAO; TROCAS METABOLICAS; POLIMORFISMO GENETICO; DIETA; VITAMINA D; QUIMIOPREVENCAO |
| 332/636 | US=14 / Câncer Siddig A, Mohamed AO, Kamal H, Awad S, Hassan AH, Zilahi E, Al-Haj M, Bernsen R, Adem A. Estrogen receptor-alpha gene polymorphism and breast cancer. In: Branicki FJ, Adem A, Ghazal-Aswad S, Torab FC. Recent advances in clinical oncology. Boston: Blackwell, 2008. p. 95-107. ISBN 978-1-57331-700-9. CANCER DE MAMA; RECEPTOR DE ESTROGENO ALFA; EXON 4; POLIMORFISMO |
| 333/636 | US=14 / Câncer Drew Y, Calvert H. The potential of PARP inhibitors in genetic breast and ovarian cancers. In: Branicki FJ, Adem A, Ghazal-Aswad S, Torab FC. Recent advances in clinical oncology. Boston: Blackwell, 2008. p. 136-45. ISBN 978-1-57331-700-9. CANCER DE MAMA; CANCER DE OVARIO; GENE BCRA1; GENE BCRA2; GENETICA DO CANCER; ADP-RIBOSILACAO; POLIMERASE-1; PARP-1; INIBIDORES DE PARP-1 |
| 334/636 | US=17 / Gastro El-Omar EM. Role of host genetic susceptibility in the pathogenesis of gastric cancer. In: Wang TC, Fox JG, Giraud AS. The biology of gastric cancers. New York: Springer, 2008. p. 235-50. ISBN 978-0-387-69181-7. CANCER GASTRICO; SUSCEPTIBILIDADE DO HOSPEDEIRO; GENETICA; HELICOBACTER PYLORI; POLIMORFISMOS DO GENE |
| 335/636 | US=23 / Biol/Mol Read A, Donnai D. Quais os efeitos das mutações. In: ___. Genética clínica: uma nova abordagem. Porto Alegre: Artmed, 2008. p. 141-71. ISBN 85-3631190-6. EFEITOS DAS MUTACOES; RUPTURA DE UM GENE; MUTACOES; HISTORICO FAMILIAR; GENOTIPOS; FENOTIPOS; MUTACOES SOMATICAS |
| 336/636 | US=23 / Biol/Mol Read A, Donnai D. Como os pesquisadores identificam os genes das doenças mendelianas?. In: ___. Genética clínica: uma nova abordagem. Porto Alegre: Artmed, 2008. p. 229-49. ISBN 85-3631190-6. DOENCAS MENDELIANAS; GENES; RASTREAMENTO DO GENE; SINDROME DE RUBINSTEIN-TAYBI |
| 337/636 | US=28 / Urologia Dhanani N, Vocke C, Bratslavsky G, Linehan WM. Molecular genetics in inherited renal cell carcinoma: identification of targets in the hereditary syndromes. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 97-114. ISBN 978-1-58829-251-3. GENETICA MOLECULAR NO CARCINOMA RENAL HEREDITARIA; SINDROMES HEREDITARIAS; VON HIPPEL-LINDAU; CARCINOMA RENAL ESPORADICO; LESOES CISTICAS EM VON HIPPEL-LINDAU; CARCINOMA PAPILAR RENAL HEREDITARIA; GENE PARA CARCINOMA PAPILAR RENAL HEREDITARIA; BIRT-HOGG-DUBE; HEREDITARIA LESIOMYOMATOSIS CARCINOMA DE CELULAS RENAIS |
| 338/636 | US=28 / Urologia Finke JH, Goel M. T-cell unresponsiveness in renal cell carcinoma patients. In: Bukowski RM, Novick AC. Clinical management of renal tumors. New Jersey: Humana Press, 2008. p. 115-30. ISBN 978-1-58829-251-3. GENETICA MOLECULAR NO CARCINOMA RENAL HEREDITARIA; SINDROMES HEREDITARIAS; VON HIPPEL-LINDAU; CARCINOMA RENAL ESPORADICO; LESOES CISTICAS EM VON HIPPEL-LINDAU; CARCINOMA PAPILAR RENAL HEREDITARIA; GENE PARA CARCINOMA PAPILAR RENAL HEREDITARIA; BIRT-HOGG-DUBE; HEREDITARIA LESIOMYOMATOSIS CARCINOMA DE CELULAS RENAIS |
| 339/636 | US=28 / Biol/Mol Teicher BA. Newer vascular targets. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 133-53. ISBN 978-1-58829-870-6. MAIS RECENTES ALVOS VASCULARES; SAGE; ENDOSSIALINA; TEM; ANGIOGENESE ANTI; VASCULAR ALVO; GENE-EXPRESSAO ANALISE |
| 340/636 | US=23 / Câncer Peiró G. Lymph node-negative breast carcinoma: assessment of HER-2/neu gene status as prognostic value. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 569-81. ISBN 978-1-4020-8368-6. CANCER DE MAMA; LINFONODO NEGATIVO; CARCINOMA DE MAMA; AVALIACAO DA HER-2/NEU; STATUS GENETICO; VALOR PROGNOSTICO; SUPEREXPRESSAO DA PROTEINA; ELISA; IMUNOHISTOQUIMICA; MRNA; AMPLIFICACAO DO GENE |